# Study In People With Type 2 Diabetes

> **NCT00196989** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 448 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** GW677954

## Key facts

- **NCT ID:** NCT00196989
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 448 (ACTUAL)
- **Last updated:** 2017-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00196989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00196989, "Study In People With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00196989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*